{
    "2020-06-04": [
        [
            {
                "time": "2023-10-16",
                "original_text": "Pliant Therapeutics Shares Have Climbed 44% Since This Week's IPO",
                "features": {
                    "keywords": [
                        "Pliant Therapeutics",
                        "Shares",
                        "Climbed",
                        "IPO"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "Novartis (NVS) Announces Positive Data From Cosentyx Study",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Positive Data",
                        "Cosentyx",
                        "Study"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",
                "features": {
                    "keywords": [
                        "Biotech Pulse",
                        "Positive Readout",
                        "Kezar",
                        "AstraZeneca",
                        "Oncology Partnership",
                        "Merck",
                        "Triple Combo Antibiotic"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}